134 related articles for article (PubMed ID: 35171311)
1. CD37 expression in follicular lymphoma.
Yoshimura T; Miyoshi H; Shimono J; Nakashima K; Takeuchi M; Yanagida E; Yamada K; Shimasaki Y; Moritsubo M; Furuta T; Kohno K; Ohshima K
Ann Hematol; 2022 May; 101(5):1067-1075. PubMed ID: 35171311
[TBL] [Abstract][Full Text] [Related]
2. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
[TBL] [Abstract][Full Text] [Related]
3. Tetraspanin CD37 protects against the development of B cell lymphoma.
de Winde CM; Veenbergen S; Young KH; Xu-Monette ZY; Wang XX; Xia Y; Jabbar KJ; van den Brand M; van der Schaaf A; Elfrink S; van Houdt IS; Gijbels MJ; van de Loo FA; Bennink MB; Hebeda KM; Groenen PJ; van Krieken JH; Figdor CG; van Spriel AB
J Clin Invest; 2016 Feb; 126(2):653-66. PubMed ID: 26784544
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37.
Peeters R; Cuenca-Escalona J; Zaal EA; Hoekstra AT; Balvert ACG; Vidal-Manrique M; Blomberg N; van Deventer SJ; Stienstra R; Jellusova J; Giera M; Hannibal L; Spiekerkoetter U; Ter Beest M; Berkers CR; van Spriel AB
Nat Commun; 2022 Sep; 13(1):5371. PubMed ID: 36100608
[TBL] [Abstract][Full Text] [Related]
5. High frequency of inactivating tetraspanin
Elfrink S; de Winde CM; van den Brand M; Berendsen M; Roemer MGM; Arnold F; Janssen L; van der Schaaf A; Jansen E; Groenen PJTA; Eijkelenboom A; Stevens W; Hess CJ; van Krieken JH; Vermaat JSP; Cleven AHG; de Groen RAL; Neviani V; de Jong D; van Deventer S; Scheijen B; van Spriel AB
Blood; 2019 Sep; 134(12):946-950. PubMed ID: 31366619
[TBL] [Abstract][Full Text] [Related]
6. CD37 in B Cell Derived Tumors-More than Just a Docking Point for Monoclonal Antibodies.
Bobrowicz M; Kubacz M; Slusarczyk A; Winiarska M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333768
[TBL] [Abstract][Full Text] [Related]
7. Pathology and diagnosis of follicular lymphoma and related entities.
Randall C; Fedoriw Y
Pathology; 2020 Jan; 52(1):30-39. PubMed ID: 31791624
[TBL] [Abstract][Full Text] [Related]
8. [Significance of CD37 expression in malignant B cells].
Wang W; Li Y; Gao L; Xu SH; Gong M; Huang FZ; Li ZL; Chen YR; Ma YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):644-7. PubMed ID: 24989269
[TBL] [Abstract][Full Text] [Related]
9. IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma.
Elfrink S; Ter Beest M; Janssen L; Baltissen MP; Jansen PWTC; Kenyon AN; Steen RM; de Windt D; Hagemann PM; Hess C; van Spronsen DJ; Hoevenaars B; van der Spek E; Xu-Monette ZY; Young KH; Kaffa C; Bervoets S; van Heek J; Hesius E; de Winde CM; Vermeulen M; van den Brand M; Scheijen B; van Spriel AB
Blood Adv; 2022 Apr; 6(7):2254-2266. PubMed ID: 35086136
[TBL] [Abstract][Full Text] [Related]
10. AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML.
Pereira DS; Guevara CI; Jin L; Mbong N; Verlinsky A; Hsu SJ; Aviña H; Karki S; Abad JD; Yang P; Moon SJ; Malik F; Choi MY; An Z; Morrison K; Challita-Eid PM; Doñate F; Joseph IB; Kipps TJ; Dick JE; Stover DR
Mol Cancer Ther; 2015 Jul; 14(7):1650-60. PubMed ID: 25934707
[TBL] [Abstract][Full Text] [Related]
11. The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model.
Beckwith KA; Frissora FW; Stefanovski MR; Towns WH; Cheney C; Mo X; Deckert J; Croce CM; Flynn JM; Andritsos LA; Jones JA; Maddocks KJ; Lozanski G; Byrd JC; Muthusamy N
Leukemia; 2014 Jul; 28(7):1501-10. PubMed ID: 24445867
[TBL] [Abstract][Full Text] [Related]
12. The tetraspanin CD37 orchestrates the α(4)β(1) integrin-Akt signaling axis and supports long-lived plasma cell survival.
van Spriel AB; de Keijzer S; van der Schaaf A; Gartlan KH; Sofi M; Light A; Linssen PC; Boezeman JB; Zuidscherwoude M; Reinieren-Beeren I; Cambi A; Mackay F; Tarlinton DM; Figdor CG; Wright MD
Sci Signal; 2012 Nov; 5(250):ra82. PubMed ID: 23150881
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.
Leich E; Zamo A; Horn H; Haralambieva E; Puppe B; Gascoyne RD; Chan WC; Braziel RM; Rimsza LM; Weisenburger DD; Delabie J; Jaffe ES; Fitzgibbon J; Staudt LM; Mueller-Hermelink HK; Calaminici M; Campo E; Ott G; Hernández L; Rosenwald A
Blood; 2011 Nov; 118(20):5550-8. PubMed ID: 21960592
[TBL] [Abstract][Full Text] [Related]
14. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
15. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
[TBL] [Abstract][Full Text] [Related]
16. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
17. CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia.
Zhang Q; Han Q; Zi J; Song C; Ge Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400873
[TBL] [Abstract][Full Text] [Related]
18. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.
Cong P; Raffeld M; Teruya-Feldstein J; Sorbara L; Pittaluga S; Jaffe ES
Blood; 2002 May; 99(9):3376-82. PubMed ID: 11964306
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression.
Montoto S; López-Guillermo A; Altés A; Perea G; Ferrer A; Camós M; Villela L; Bosch F; Esteve J; Cervantes F; Bladé J; Nomdedeu B; Campo E; Sierra J; Montserrat E
Ann Oncol; 2004 Oct; 15(10):1484-9. PubMed ID: 15367408
[TBL] [Abstract][Full Text] [Related]
20. DuoHexaBody-CD37
Oostindie SC; van der Horst HJ; Kil LP; Strumane K; Overdijk MB; van den Brink EN; van den Brakel JHN; Rademaker HJ; van Kessel B; van den Noort J; Chamuleau MED; Mutis T; Lindorfer MA; Taylor RP; Schuurman J; Parren PWHI; Beurskens FJ; Breij ECW
Blood Cancer J; 2020 Apr; 10(3):30. PubMed ID: 32341336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]